8 Einträge gefunden

1. Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis

   1. Schlenk, R F
   2. Stegelmann, F
   3. Reiter, A
   4. Jost, E
   5. Gattermann, N
   6. Hebart, H
   7. Waller, C

   2017 - Forschungsinformationssystem des UKE
2. Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5)

   1. Schuler, E
   2. Giagounidis, A
   3. Haase, D
   4. Shirneshan, K
   5. Büsche, G
   6. Platzbecker, U
   7. Nolte, F

   2016 - Forschungsinformationssystem des UKE
3. Efficacy and safety of deferasirox in non-thalassemic patients with elevated ferritin levels after allogeneic hematopoietic stem cell transplantation

   1. Jaekel, N
   2. Lieder, K
   3. Albrecht, S
   4. Leismann, O
   5. Hubert, K
   6. Bug, G
   7. Kröger, Nicolaus

   2016 - Forschungsinformationssystem des UKE
4. Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)

   1. Mossner, M
   2. Jann, J-C
   3. Nowak, D
   4. Platzbecker, U
   5. Giagounidis, A
   6. Götze, K
   7. Letsch, A

   2016 - Forschungsinformationssystem des UKE
5. SETBP1 mutation analysis in 944 patients with MDS and AML

   1. Thol, F
   2. Suchanek, K J
   3. Koenecke, C
   4. Stadler, M
   5. Platzbecker, U
   6. Thiede, C
   7. Schroeder, T

   2013 - Forschungsinformationssystem des UKE
6. Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantation

   1. Schroeder, T
   2. Fröbel, J
   3. Cadeddu, R-P
   4. Czibere, A
   5. Dienst, A
   6. Platzbecker, U
   7. Bug, G

   2013 - Forschungsinformationssystem des UKE
7. Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation

   1. Schroeder, T
   2. Czibere, A
   3. Platzbecker, U
   4. Bug, G
   5. Uharek, L
   6. Luft, T
   7. Giagounidis, A

   2013 - Forschungsinformationssystem des UKE
8. 5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis.

   1. Czibere, A
   2. Bruns, I
   3. Kröger, Nicolaus
   4. Platzbecker, U
   5. Lind, J
   6. Zohren, F
   7. Fenk, R

   2009 - Forschungsinformationssystem des UKE